Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- F-1 Registration statement (foreign)
- 3.1 Articles of Association of Scinai Immunotherapeutics LTD
- 5.1 Opinion of Goldfarb Gross Seligman & Co., Israeli Counsel to the Company, Regarding the Validity of the Adss Being Registered
- 23.1 Consent of Kost Forer Gabbay & Kasierer, Certified Public Accountant (Isr.), a Member of Ernst & Young Global, Independent Registered Public Accounting Firm for the Registrant
- EX-FILING FEES Filing Fee Table
Associated filings
- 2 Jan 24 424B3 Prospectus supplement
- 2 Jan 24 424B3 Prospectus supplement
- 27 Dec 23 EFFECT Notice of effectiveness
- 22 Dec 23 F-1/A Registration statement (foreign) (amended)
-
30 Oct 23 F-1 Registration statement (foreign)
SCNI similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in this Registration Statement (Form F-1) and related prospectus of Scinai Immunotherapeutics Ltd. of our report dated April 17, 2023, with respect to the financial statements of Scinai Immunotherapeutics Ltd. included in its Annual Report (Form 10-K) for the year ended December 31, 2022, filed with the Securities and Exchange Commission.
/s/ Kost Forer Gabbay & Kasierer |
Kost Forer Gabbay & Kasierer |
A member firm of Ernst & Young Global
Tel Aviv, Israel
October 30, 2023